-
-
Call more information
660-596-2224 -
Anesthesia & Analgesia: September 2016 – Volume 123 – Issue 3 – p 731–738 AUTHORS: Sigakis, Matthew J. G. MD et al BACKGROUND: Discharge diagnoses are used to track national trends and patterns of maternal morbidity. There are few data regarding the validity of the International Classification of Diseases (ICD) codes used for this purpose. The goal […]
Read MoreAnesthesia & Analgesia: September 2016 – Volume 123 – Issue 3 – p 715–721 AUTHORS: Schwartz, Lawrence I. MD et al BACKGROUND: Dexmedetomidine is a selective α-2 receptor agonist with a sedative and cardiopulmonary profile that makes it an attractive anesthetic for pediatric patients with congenital heart disease (CHD). Although several smaller, single-center studies suggest […]
Read MoreAnesthesia & Analgesia: September 2016 – Volume 123 – Issue 3 – p 705–714 AUTHORS: Chau, Destiny F. MD et al BACKGROUND: Complex surgical and critically ill pediatric patients rely on syringe infusion pumps for precise delivery of IV medications. Low flow rates and in-line IV filter use may affect drug delivery. To determine the […]
Read MoreAnesthesia & Analgesia: September 2016 – Volume 123 – Issue 3 – p 698–702 AUTHORS: Downing, John W. MD et al BACKGROUND: Vasoactive agents administered to counter maternal hypotension at cesarean delivery may theoretically intensify the hypoxemic fetoplacental vasoconstrictor response and, hence, negatively impact transplacental oxygen delivery to the fetus. Yet, this aspect of their […]
Read MoreAnesthesia & Analgesia:September 2016 – Volume 123 – Issue 3 – p 690–697 AUTHORS: Sviggum, Hans P. MD et al BACKGROUND: Intrathecal (IT) morphine is considered the “gold standard” for analgesia after cesarean delivery under spinal anesthesia, most commonly administered at a dose of 100 to 200 μg. There is less experience with IT hydromorphone […]
Read More